Breaking News on Pharmaceutical Technology
All news articles > October 2006
| « Previous month | Next month » |
31-Oct-2006
BioWa begins Phase 1 clinical Mab trial in asthma
BioWa has announced it is to commence Phase 1 clinical trials anti-IL-5 receptor monoclonal antibody (Mab), which is being developed for the treatment of asthma, a respiratory disorder that is on the rise, particularly in children.
Oval film-coated tablets 'easier to swallow', says research
Patients can more easily swallow film-coated oval shaped tablets than any other commonly manufactured solid drugs, according to a new study.
GE's IP expert offers tips on China
China offers Western firms a huge opportunity, but those operating in the country should be very mindful of introducing key technologies.
Drug delivery breakthrough for brain tumour therapy
A start-up company has given new hope for patients with brain tumour by developing a new medical device that it claims is the first ultrasound-based system to allow drug delivery to the brain.
Cardinal claims to hold the key to contract packaging success
Cardinal Health said it is leading the way in contract pharma packaging and attributes its success to reducing supplier base and improving supply chain efficiency to save its customers time and money.
30-Oct-2006
Contract manufacturing biz to exceed $26bn
The global contract manufacturing market is expected to exceed $26bn (€20bn) by 2011, according to new market research.
Canada emerges as Western hub for cost effective drug making
Canada has established itself as a Western hub for cost-effective pharma manufacturing according to a report comparing international business costs.
Contract packaging - a strategic move
The contract packaging biz is moving from an ad-hoc to a more strategically determined, long-term approach, as pharma companies begin to relax in the arms of service providers.
New FDA guidance for out-of-specification test results
The US Food and Drug Administration (FDA) has announced the launch of a new guidance to help drug makers evaluate lab test results that fall outside the specification limits.
27-Oct-2006
China gaining ground in outsourcing supremacy
A recent report that focuses on international research and development trends has placed China as the country gaining significant grounds on the US in terms of R&D spending and outsourcing capabilities.
Gerresheimer announces latest plastics plans
Gerresheimer has announced it will launch a new plastic syringe range in January to cater for highly-sensitive medications and also for high-volume injections.
DSM pushes forward with global vision
A year after it published its five-year strategy: Vision 2010 - Building on Strengths - DSM's commitment is showing no sign of slowing as is continues to invest in the expansion of its pharmaceutical production capabilities around the globe.
Cleveland BioLabs glowing after radioprotection drug deal
US-based drug maker Cleveland BioLabs has teamed up with biopharmaceutical manufacturer Synco Bio Partners to produce its leading radioprotection molecule for clinical trials and commercialisation
Inhalable insulin may be a 'flop', says report
Inhalable insulin is unlikely to achieve the blockbuster status the industry had hoped for, according to a new Datamonitor report.
26-Oct-2006
'Take China seriously,' says IP veteran
IBM's vice president of Intellectual Property (IP) Strategy, Kevin Rivette, gives his views on the IP state-of-play on the ground in China.
Cambrex strips itself to the core with sale of major units
Cambrex has stripped itself to the core after selling two of its three business units and two further manufacturing facilities this week.
Aspectrics reaches out to Asian market
Lab equipment supplier Aspectrics is expanding its products distribution to the Asian market thanks to a new deal signed with South Korean analytical instrument provider Young Lin.
Systech launches packaging automation system
Systech has launched a new packaging line automation solution that it claims will help drug makers address their manufacturing line inefficiencies.
25-Oct-2006
Lilly injects $560m into US biotech plant expansion but will shut UK plant
Drug maker Eli Lilly has completed the first phase of a $560m (€446m) expansion of its biotech facility in Indianapolis, US, in order to match the growing number of biological drugs in its pipeline.
Continuous coating firm eyes Europe
O'Hara Technologies chose the recent CPhI in Paris to show off the world's only dedicated continuous coating machine for pharmaceutical tablets.
Curalogic appoints SAFC to provide protein research services
Curalogic, a Danish biotechnology company, has appointed SAFC's Pharma business segment to provide protein isolation, extraction and purification services as part of its product development to treat Allergic Rhinitis.
A world of outsourcing awaits - part III drug manufacturing
Although manufacturing is the most established of the pharma outsourcing segments, many service areas are still rapidly evolving. OutsourcingPharma.com gives a brief run down of the current state of play.
European cardiovascular drugs market set to rocket to new heights
According to a new study the European cardiovascular drugs market is expected to reach $36.3bn (€28.9bn) in 2012, buoyed on by new drug areas, classes and combination products.
24-Oct-2006
Dry-powder inhaler 'revolution' unveiled
A new dry powder inhaler that may cost less than a syringe and deliver 40 per cent more active drug than current inhalers has been unveiled by its maker, Cambridge Consultants.
Enzyme profile offers insights into tumourgenesis
Findings from new study have offered an innovative profile of an enzyme that aids tumour growth, which points towards a potential new target for treatments for ovarian and breast cancers.
Eli Lilly buys erectile dysfunction drug partner ICOS
Eli Lilly has splashed out $2.1bn (€1.7bn) to buy ICOS, who the drug giant has been involved in a joint venture with to manufacture and sell Cialis (tadalafil) - the number two erectile dysfunction drug behind Viagra (sildenafil).
FDA to review electronic signature regulation
The Food and Drug Administration (FDA) is expected to issue a revised version of its regulation on electronic signatures and records by the end of the year, which will force drug and device companies to reconsider their current information management systems.
Big Pharma splash out on R&D
Developing new drugs represents an enormous expense for pharma companies with top firms spending up to £4bn (€6bn) a year on R&D, according to new industry report.
23-Oct-2006
Indian-made blister machine promises savings
A "faster and cheaper" blister pack machine was launched by Indian-firm Cap Tab for the first time in Europe at this year's CPhI in Paris.
Contamination risks challenge clinical supply manufacturers
Minimising the risk of cross-contamination in the production of medicines for use in clinical trials is a major challenge for manufacturers, who need to implement safety measures in order to avoid production failure.
FDA gets tougher on new drug approvals
Fewer first cycle new drug approvals by the US Food and Drug Administration (FDA) could be the first evidence of a toughening regulatory environment, according to new research.
Overcoming intellectual property phobia in China
China is a big market with a lot of potential but many pharma industry firms still avoid doing business in the country because of fears that their intellectual property (IP) cannot be protected.
20-Oct-2006
Big pharma business model needs to change
The current big pharma business model is not sustainable for the future and will need to change, delegates heard at the recent Financial Times (FT) global Pharmaceuticals and Biotechnology Conference.
Evolutec to outsource manufacture of new autoimmune disease drug
UK Biopharma company Evolutec has signed a deal with Wacker Biotech to produce Evolutec's new autoimmune disease drug candidate rEV576 for clinical trials.
Bangladesh and The Gambia get in on drug manufacturing
Two new drug manufacturing facilities have been launched in global areas that don't usually see much pharmaceutical manufacturing activity - Bangladesh and The Gambia.
e-learning could ease regulatory training headaches
Biopharma and lifesciences firms should make use of e-learning software solutions to relieve the burden on keeping staff updated on regulatory and compliance training.
US and EU pharma trade bodies slam poor regulation of foreign APIs
Two trade associations of the world's two largest pharma economies - Europe and the US - took the unusual step of banding together at the CPhI in Paris to condemn their regulatory authorities for poor regulation of foreign active pharmaceutical ingredient (API) manufacturers.
19-Oct-2006
Pharma to set precedent for RFID integration
The pharmaceutical sector will have a major influence on how the integration of RFID technology is spread across other industries, according to research firm Venture Development Corporation (VDC).
Pakistan's pharma industry says "me too"
Two of Pakistan's pharma industry representatives spoke at the CPhI in Paris to raise the profile of this evolving sector of the country's economy.
DSM accelerates anti-infective activity
Using a processing technique described as "revolutionary," DSM is accelerating its activity in the anti-infective arena and targeting new active pharmaceutical ingredients (APIs) that it can develop into cost-competitive generic versions.
US FDA introduces accelerated generic drug reviews
The Food and Drug Administration are set to introduce a series of measures that will accelerate the review process for generic drugs, placing a priority on therapies that would address a public health emergency or nationwide shortage.
18-Oct-2006
Contract manufacturing linked to underperformance, says report
Firms engaging in both in-house and contract pharma manufacturing generally display inferior performance compared to manufacturers conducting only in-house production, according to new research.
Saltigo expands capacity as fine chemicals industry stabilises
Service provider Saltigo is reinforcing its position in the stabilising fine chemical custom manufacturing industry by investing in the expansion of its German facility.
SAFC takes on transgenics and India
Sigma-Aldrich Group member SAFC made its presence felt at the recent CPhI in Paris with announcements regarding its expansion activities in transgenic manufacturing and India.
Lexicon Genetics initiates study for anti-autoimmune drug
Lexicon Genetics has revealed details of the preclinical development of a novel, orally available small molecule compound with potential application in the treatment of autoimmune diseases such as multiple sclerosis and rheumatoid arthritis.
Arkema unveils green catalyst
Arkema has unveiled a new green oxidation catalyst that it claims "makes environmental protection a priority," as well as launching a new product website.
17-Oct-2006
Pfizer outsources API manufacture to Asia
Pfizer CentreSource has decided to outsource the manufacture of some of its active pharmaceutical ingredients (API) to two Asian contract manufacturers and intends to work with the Food and Drug Administration's (FDA) during the process.
Green emerges triumphant over industry in latest REACH wrangle
Environmental representatives have emerged triumphant in the latest round of negotiations over the finer bones of contention of the European REACH chemicals legislation, due to come in force in April next year.
Researchers discover sugar compound wards off seizures
Researchers have demonstrated that a new compound has the potential to effectively cure epilepsy, raising hopes that a new drug can be produced to treat epileptic patients, who currently have no access to treatment.
Isopak to offer packaging equipment sourcing service
Equipment supplier Isopak has launched a new sourcing service to meet the manufacturing needs of its clients.
LifeCycle signs three deals for new drug delivery system
LifeCycle has signed three collaboration agreements with big pharma companies for the development of new anti-cholesterol products using its novel drug delivery technologies.
16-Oct-2006
Sandoz wades deeper into generic biopharmaceuticals
As it looks to the "future of pharmaceuticals," Sandoz is planning a "powerful biopharmaceuticals programme" with the construction of a new biopharmaceuticals development centre in Ljubljana, Slovenia.
Excelsyn chases process improvement
Excelsyn Molecular Development claims to have made a "major advance" in a protein intensification process that can be used to slash the manufacturing costs of a range of amino acids.
External sourcing fuelling mid pharma development
By 2010 nearly half of all mid pharma firm revenues will be derived from products that have been discovered outside of in-house development pipelines, says a new report from independent market analyst Datamonitor.
Pharma firms manufacturing waste costs $50bn, report warns
The US pharmaceutical industry could be wasting more than $50bn (€39bn) per year in manufacturing costs due to inefficient processes, a new research has warned.
Indena steps up efforts in "natural drug" market
Italian pharma company Indena is strengthening its position in the "natural drug" market - where drug molecules are derived from plants - a potentially lucrative niche area of pharmaceuticals.
13-Oct-2006
NovaThera and Pharming to develop new bioactive materials
NovaThera and Dutch biotech company Pharming have pooled their resources to develop a new generation of bioactive materials aimed at the delivery of therapeutic transgenic proteins.
New report: India's top 100 pharmaceutical firms
A new report is available detailing the top 100 Indian pharmaceutical companies for those in the industry who have a business interest in this burgeoning region.
Aesica snaps up Merck UK facility
British pharma company Aesica has bought a chemical manufacturing facility from Merck Sharp and Dohme (MSD), Merck's UK subsidiary, in a bid to increase it manufacturing capacities.
12-Oct-2006
Codexis weighs into generics biz via India
Codexis is using India as a springboard to launch it into direct sales of high-value generic pharmaceutical intermediates, to be sold into unregulated markets for use in patented drugs.
Pall to expand biopharma manufacturing in Puerto Rico
Filter maker Pall Corporation has announced its plan to invest about $50m (€63.5m) to expand its life sciences manufacturing operations in Puerto Rico and take advantage the island's low tax regime.
Nicholas Piramal targets Europe with new innovation centre
In its ambition to become one of the top three global players in custom manufacturing, the UK subsidiary of drug-maker Nicholas Piramal (NPIL) has created a new "innovation unit" in Europe.
Rhodia provides process and handling updates
Rhodia was present at this year's CPhI, alerting the industry to its latest product updates, spawned out of the market demand to provide products that allow its customers to better address process and handling requirements.
11-Oct-2006
Pfizer pushes forward into vaccine market
US drug heavyweight Pfizer is pushing through into the increasingly profitable vaccine market with the purchase of privately held UK firm PowderMed for an undisclosed sum.
Sigma makes bid to dominate Australian drug market
Australia's Sigma Pharmaceuticals is attempting to take over the reigns of smaller domestic rival Australian Pharmaceutical Industries (API) in a move that if successful, would allow it to control two thirds of the $9bn Australian pharma market.
Raylo praises pH sensor for "radical process improvement"
Raylo Chemical says that it has reduced its manufacturing cycles by up to 20 per cent and as a result saved hundreds of thousands of dollars per year after it installed new pH sensing technology.
Xcelience to expand headquarters in Florida
Formulation development company Xcelience has announced its plan to expand its headquarters in Tampa, Florida to meet higher customers' demand.
Data warehouse identified as key to future drug R&D
The need for better exploitation of clinical data is linked directly to the general challenges facing drug development today as development costs for new products have rocketed from $100m (€79m) to $800m.
10-Oct-2006
Reaxa to launch new product-saving scavenging resins
Reaxa has chose the recent CphI to announce it is developing a new addition to its range of scavenging resins that it claims allows a huge reduction in product loss in the process of precious metals clean-up.
Cardinal attracts Wyeth as cell line engineering market remains "robust"
Cardinal Health says it is experiencing a "robust market" for its cell line engineering technology, as it attracts the attention of pharma giant Wyeth and executes capacity expansion plans its for full service offerings in the field.
Eurand to co-develop GSK drug
Italian drug delivery technology developer Eurand has signed a $42m (€33m) licensing deal with GlaxoSmithKline (GSK) to make a new formulation of one of the British pharma giant's drugs.
Shire Pharmaceuticals opens new technology centre in Baltimore
British pharma company Shire has opened a new $6m (€4.7m) pharmaceutical technology centre at its Baltimore, Maryland plant in order to improve its manufacturing capability.
Dragon launches new nanotechnology-based packaging products
Dragon International Group has launched two new packaging products developed through the use of nanotechnologies that could potentially replace the currently used packaging on the market such as plastic and PVC.
09-Oct-2006
Capsulution and Ebara team up on new drug delivery system
Japanese firm Ebara and Berlin-based Capsulution NanoScience are now working together to develop a new time-controlled release technology for pharmaceuticals.
Prosonix pushes sonocrystallisation forward
Prosonix has launched a new particle engineering technology in an attempt to reach the inhaled drug delivery market - at the same time the British firm has extended an agreement with UCB for the use of its existing sonocrystallisation technology.
Tech Group seeks bigger facility as demand rockets
Injection molder and contract manufacturer Tech Group is relocating its Grand Rapids plant to a new molding facility in nearby Walker, Michigan, which will be expanded to cope with the high demand for medical devices and components.
European countries hailed as top locations for business
Switzerland, Finland and Sweden are the world's most competitive economies according to this year's assessment of the best places to do business by the Switzerland-based World Economic Forum (WEF).
06-Oct-2006
UK pharma faces recruitment issues, report warns
UK pharmaceutical companies are not doing enough to attract fresh talent to the industry and face serious future recruitment issues if they don't get their act together now, warns a new report.
Inyx buys Pharmapac to enrich its offerings
In a deal worth up to $19.9m (€15.6m), US drug delivery company Inyx has acquired contract pharmaceutical packaging firm Pharmapac, seeking to enhance its secondary-packaging capabilities for a wide range of dosage forms.
'Lactose library' launched on the internet
Everything you ever wanted to know about lactose in pharmaceutical applications can now be found on a new website dedicated to the milky molecule.
New drug provides effective defence against bird flu
A new study has discovered what seems to be a novel compound that offers protection against influenza viruses, including the bird flu virus. The compound could represent a new class of antiviral drugs to prevent and treat this killer threat.
FDA says drug safety reforms "are on the way"
The US Food and Drug Administration (FDA) has admitted that more needs to be done to ensure the safe and effective use of prescription drugs, after a report urged the regulator to revamp its drug safety system.
05-Oct-2006
Report: FDA needs overhaul in drug safety process
The US Food and Drug Administration (FDA) has come under scrutiny after an independent report urged the regulator to implement large reforms to ensure the safety of new prescription drugs.
GSK lets Chinese firm manufacture flu drug
Responding to Roche's licensing agreements for Tamiflu (oseltamivir phosphate) around the world, GlaxoSmithKline (GSK) has granted China's Simcere Pharmaceutical Group the right to make generic copies of its influenza drug Relenza (zanamivir for inhalation) for developing countries.
Gerresheimer launches new container closure system
Germany-based drug packaging provider Gerresheimer has launched a new closure system for tablet containers with a moisture-absorbing system that it claims is unique in the market.
04-Oct-2006
Discovery Labs looks to FDA to end manufacturing ordeal
Following numerous manufacturing failures, Discovery Laboratories believes it has resolved the stability issues that have plagued Surfaxin, its experimental respiratory treatment for infants, and is now seeking a meeting with the US Food and Drug Administration (FDA) to address its concerns.
EU Commission accused of anti-industry "green policies"
The European Commission continues to be accused by European industry of pushing 'green policies' that are stifling progress and global competitiveness - the controversial REACH chemicals legislation remains a sore point.
Apollo confident of oral insulin breakthrough
Biotechnology firm Apollo claims to have achieved mission impossible in the oral delivery of insulin by successfully lowering blood glucose levels in diabetic rats using its proprietary oral delivery technology.
Wockhardt to build manufacturing hub in India
Indian biopharmaceutical company Wockhardt has signed a deal with Maharashtra Industrial Development Corporation (MIDC) to establish a special economic zone (SEZ) in Aurangabad, India, in order to expand its manufacturing capabilities.
Tepnel launches new disinfectant testing service
UK-based Tepnel Scientific Services has launched a new pharmaceutical outsourcing solution - disinfectant testing - aimed at the pharmaceutical and biopharmaceutical industries, as well as disinfectant manufacturers.
03-Oct-2006
Dr. Reddy's launches new finished dosage plant in India
Dr. Reddy's Laboratories has announced the inauguration of its seventh finished dosage plant in India, reflecting the country's unprecedented growth as a generic pharmaceuticals manufacturer.
Uetikon stakes claim in bio-outsourcing market
A majority stake in Irish biotechnology contract services firm Archport has been snapped up by German-based Chemie Uetikon as the bio-outsourcing market heats up.
Merck's blockbuster hopeful suffers formulation setback
Merck has been forced to delay marketing plans for its combination cholesterol drug MK-0524B following problems in formulating its top-selling statin Zocor (simvastatin) with a new promising compound under development, MK-524A.
FDA pushes cell-based production of viral vaccines
The US Food and Drug Administration (FDA) has issued new advice to aid manufacturers in developing safe and effective cell-based viral vaccines, hoping it can modernise America's manufacturing network and speed up production.
Nanoparticle drug delivery could replace eye drops
Researchers have discovered a new method for delivering drugs to the eye using biodegradable polymer nanoparticles that promise controlled release and better bioavailability than eye drops.
02-Oct-2006
Glaxo splashes out €500m on French vaccine plant
With sales of its vaccines expected to triple in the next ten years, GlaxoSmithKline (GSK) has decided to invest more than €500m in a new manufacturing facility in St-Amand-Les-Eaux in order to increase production capacity for paediatric and adult vaccines.
Top pharmaceutical RFID vendors put their heads together
The pharma industry's leading radio frequency identification (RFID) vendors recently gathered to share expertise and evaluate the potential of their RFID technologies in a living laboratory, in their quest to produce a market viable solution to drug counterfeiting and supply chain tracking.
New FDA guidance on cGMP
Drug manufacturers can better understand how they can achieve regulatory compliance and avoid production stoppages and recalls by following new guidance issued by the US Food and Drug Administration (FDA).
Generic drug firm boss charged with ID fraud
The founder of start-up pharmaceutical company has been charged in a US federal court with assuming the identity of an employee of Nabi Biopharmaceuticals in order to obtain information useful in the generic production of a kidney drug.
Aptuit spreads its wings with EaglePicher API deal
Drug developing services provider Aptuit has acquired the pharmaceutical services division of technology firm EaglePicher, enriching its active pharmaceutical ingredient (API) and drug substance manufacturing offerings.
| « Previous month | Next month » |
Sign up for your free newsletter
On-Demand Webinars, Videos, Audio
- POLYOX™ - New Applications in ER Matrices
Colorcon-CP-Pharma-2008 - Meet the requirements for GSDP for pharmaceutical products
SGS - Micro Reactors - The Future for Cost-Effective Manufacturing
DSM Pharmaceutical Products - Shoot for share: from vial to pre-filled syringe
Baxter - Increase your webinar performance with expert tips and advice
Decision News Media - Modern Chemical Development and cGMP Synthesis: When to use Chiral Chromatography
Novasep
Technical & Research papers
- SOTAX offers Upgrades for outdated Zymark TPW II and Prelude Models
Sotax AG - An Introduction to High-Potent API Classification
SAFC Pharma - SonoLab™ to Prosonitron® - Sonocrystallization Proven Across Scale
Prosonix - Making Better Medicines - Super Refined Excipients - Stability Enhancement and Topical Delivery of an API
Croda - Automated determination of active-substance content
Metrohm - Surface Dissolution Imaging Gives Insight Into Bioavailability
Paraytec Ltd - Increasing Demand for Fully Automated Dissolution Sinker Retrieval Prompts New Product Development
Sotax AG - The Twist N’Use – The economical plastic alternative to the glass ampoules.
Coradin - Ultrasonic Particle Engineering – The Key to Making Better MedicinesTM
Prosonix - Making Better Medicines - Solution for Automating Content Uniformity and Assay Testing
Sotax AG
Products, Brochures, Web links
- CD Linear, the linear tube filling machine according to CO.MA.DI.S.
IMA - Track & Trace solutions from the IMA Group
IMA - New Unica220 by Marchesini Group: versatile and ergonomic thermoformer
Marchesini Group Spa - The primary Dual Vials system – Keep Safe and preserve your active ingredient
Coradin - SPI Pharma: Formulating Success Through Innovation
SPI Pharma - Purac in the pharmaceutical industry
Purac Biochem bv - Derek for Windows
Lhasa Limited
Related sites
All Decision News Media Sites
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
© 2000/2009 - Decision News Media SAS - All right reserved.
